Tenax Therapeutics Inc
TENX
Market Cap$23.65M
Close$
$6.21
9.5% upside
Current Fair Value
9.5% upsideUndervalued by 9.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $23.65 Million |
|---|---|
| Enterprise Value | $-85,961,607.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.15 |
| Beta | 1.62 |
| Outstanding Shares | 36,584,920 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.61 |
|---|---|
| PEG | 2.3 |
| Price to Sales | - |
| Price to Book Ratio | 2.84 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 8.61 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tenax Therapeutics Inc
CEO: John Kelley